» Articles » PMID: 11477557

High Frequency of Mitochondrial DNA Mutations in Glioblastoma Multiforme Identified by Direct Sequence Comparison to Blood Samples

Overview
Journal Int J Cancer
Specialty Oncology
Date 2001 Jul 31
PMID 11477557
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

In an earlier study, we showed that heteroplasmy in the mitochondrial genome of gliomas sometimes occurs in a D-loop polycytosine tract. We extended this study by pairwise comparisons between glioma samples and adjacent brain tissue of 55 patients (50 glioblastomas, 1 astrocytoma WHO grade III, 4 astrocytomas WHO grade II). We used a combination of laser microdissection and PCR to detect and quantify variations in the polycytosine tract. New length variants undetectable in the adjacent brain tissue were observed in 5 glioblastomas (9%). In 2 of these cases, samples from a lower tumor stage (WHO grade II) could be analyzed and revealed the early occurrence of these mutations in both cases. Since the mitochondrial D-loop contains additional repeats and highly polymorphic non-coding sequences, we compared 17 glioblastomas with the corresponding blood samples of the same patients by direct sequencing of the complete D-loop. In 6 of these tumors (35%), instability was detected in 1 or 2 of 3 repeat regions; in 1 of these repeats, the instability was linked to a germline T-to-C transition. Furthermore, of 2 tumors (12%) 1 carried 1 and the other 9 additional transitions. In the latter patient, 6.7 kb of the protein coding mtDNA sequence were analyzed. Six silent transitions and 2 missense mutations (transitions) were found. All base substitutions appeared to be homoplasmic upon sequencing, and 89% occurred at known polymorphic sites in humans. Our data suggest that the same mechanisms that generate inherited mtDNA polymorphisms are strongly enhanced in gliomas and produce somatic mutations.

Citing Articles

Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumors.

Kabelikova P, Ivovic D, Sumbalova Z, Karhanek M, Tatayova L, Skopkova M Cancer Drug Resist. 2025; 7():54.

PMID: 39802950 PMC: 11724352. DOI: 10.20517/cdr.2024.141.


The effect of somatic mutations in mitochondrial DNA on the survival of patients with primary brain tumors.

Mohd Khair S, Ab Radzak S, Idris Z, Mat Zin A, Wan Ahmad W, Yusoff A Croat Med J. 2024; 65(2):111-121.

PMID: 38706237 PMC: 11074945.


D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.

Szmyd B, Stanislawska P, Podstawka M, Zaczkowski K, Izbinski P, Kulczycka-Wojdala D Int J Mol Sci. 2024; 25(8).

PMID: 38673919 PMC: 11050196. DOI: 10.3390/ijms25084334.


Mitochondrial DNA Changes in Respiratory Complex I Genes in Brain Gliomas.

Kozakiewicz P, Grzybowska-Szatkowska L, Ciesielka M, Calka P, Osuchowski J, Szmygin P Biomedicines. 2023; 11(4).

PMID: 37189801 PMC: 10135735. DOI: 10.3390/biomedicines11041183.


Research highlights on contributions of mitochondrial DNA microsatellite instability in solid cancers - an overview.

Yusoff A, Abd Radzak S, Mohd Khair S Contemp Oncol (Pozn). 2022; 26(1):8-26.

PMID: 35506039 PMC: 9052346. DOI: 10.5114/wo.2022.115674.